Investigational Site Number 840009 — Newark, New Jersey

Investigational Site Number 840009 is a clinical research site located in Newark, New Jersey, United States 07112.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number 840009 has participated in 1 clinical trials.

Therapeutic areas: Hematopoietic Neoplasm.

Sponsors: Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840009?

Investigational Site Number 840009 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840009 conducted?

Investigational Site Number 840009 has 1 clinical trials on record. Their work covers Hematopoietic Neoplasm.

Is Investigational Site Number 840009 accredited by Crixeo Health?

Investigational Site Number 840009 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840009?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.